Effect of Cumin on prediabetic patients.

Phase 3

Conditions: Pre diabetes.
Abnormal glucose tolerance test

Registration Number: IRCT2016111930962N1

Lead Sponsor: Vice President of Research, Shahrekord University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 64

Inclusion Criteria

FBS between 100-125mg/dl or 2 hours after GTT (75mg glucose) BS between 140-199 mgldl or HbA1C between 5.7-6.7; Patients without liver, renal, or endocrine disorders or malignancy; Patients who do not use any drugs with significant interaction with cumin like anti-depressant; Willing to participation and filling the written consent

Exclusion criteria: not willing to participation; disobedience from the study protocol; having special diets; any liver, renal, or endocrine disorders or malignancy during the intervention; consuming vitamin D, omega-3, selenium, or anti-depressant drugs; change in the drug history during the intervention
7-using insulin

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FBS (glycemic index). Timepoint: Before (day 0) and after intervention (after 10 weeks intervention). Method of measurement: Valid biochemistry kits (Pars Azmoon).;HbA1C (glycemic index). Timepoint: Before (day 0) and after intervention (after 10 weeks intervention). Method of measurement: Valid biochemistry kits (Pars Azmoon).;Insulin (glycemic index). Timepoint: Before (day 0) and after intervention (after 10 weeks intervention). Method of measurement: Valid biochemistry kits (Pars Azmoon).

Secondary Outcome Measures

Name	Time	Method
ipid profile. Timepoint: Before and after intervention. Method of measurement: Valid biochemistry tests.;Serum leptin. Timepoint: Before and after intervention. Method of measurement: Elisa kit.